These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24319213)

  • 1. Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies.
    Gea-Banacloche J
    Hematology Am Soc Hematol Educ Program; 2013; 2013():414-22. PubMed ID: 24319213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
    Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
    Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
    Karthaus M; Hentrich M
    Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.
    Girmenia C; Aversa F; Busca A; Candoni A; Cesaro S; Luppi M; Pagano L; Rossi G; Venditti A; Nosari AM; ; ; ; ;
    Hematol Oncol; 2013 Sep; 31(3):117-26. PubMed ID: 23037867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical amphotericin B therapy on day 4 or day 8 of febrile neutropenia.
    Malhotra P; Makkar A; Guru Murthy GS; Varma N; Varma S; Chakrabarti A
    Mycoses; 2014 Feb; 57(2):110-5. PubMed ID: 23844563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.
    Cheng S; Zhou JF; Zou P; Huang XJ; Jin J; Shen ZX
    Chin Med J (Engl); 2011 Nov; 124(22):3670-5. PubMed ID: 22340222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of infections during intensive treatment of hematologic malignancies.
    Maschmeyer G; Hiddemann W; Link H; Cornely OA; Buchheidt D; Glass B; Adam D
    Ann Hematol; 1997; 75(1-2):9-16. PubMed ID: 9322678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical antifungal therapy in selected patients with persistent febrile neutropenia.
    Aguilar-Guisado M; Espigado I; Cordero E; Noguer M; Parody R; Pachón J; Cisneros JM
    Bone Marrow Transplant; 2010 Jan; 45(1):159-64. PubMed ID: 19525983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febrile neutropenia in hematologic malignancies.
    Keng MK; Sekeres MA
    Curr Hematol Malig Rep; 2013 Dec; 8(4):370-8. PubMed ID: 23990311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
    Kanda Y; Kimura SI; Iino M; Fukuda T; Sakaida E; Oyake T; Yamaguchi H; Fujiwara SI; Jo Y; Okamoto A; Fujita H; Takamatsu Y; Saburi Y; Matsumura I; Yamanouchi J; Shiratori S; Gotoh M; Nakamura S; Tamura K;
    J Clin Oncol; 2020 Mar; 38(8):815-822. PubMed ID: 31977270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Febrile neutropenia in onco-hematology patients hospitalized in Intensive Care Unit].
    Saillard C; Sannini A; Chow-Chine L; Blache JL; Brun JP; Mokart D
    Bull Cancer; 2015 Apr; 102(4):349-59. PubMed ID: 25799163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile neutropenia in haematological malignancies.
    Sharma A; Lokeshwar N
    J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China.
    Yuan W; Ren J; Guo X; Guo X; Cai S
    Med Sci Monit; 2016 Nov; 22():4226-4232. PubMed ID: 27819257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.